3Suppliers
0Customers
3Debt Items
17Related Chains

LeonaBio, Inc. Suppliers

TickerNameConfidenceEvidence
SERMONIX SERMONIX 92% As consideration for the rights granted to the Company under the Sermonix License Agreement entered into between the Company and Sermonix on December 18, 2025, the Company issued to Sermonix the Serm…
SHANGHAI-HENLIUS-BIOTECH-INC SHANGHAI-HENLIUS-BIOTECH-INC 85% the Company is coordinating with Sermonix and Shanghai Henlius Biotech, Inc. (“ Henlius ”), Sermonix’s exclusive licensee for oral lasofoxifene in Asia and certain countries in the Middle East
LIGAND LIGAND 80% we entered into a direct license agreement with Ligand (the "Ligand Agreement") to replace Sermonix's license from Ligand

LeonaBio, Inc. Customers

No clients on recordNo downstream customers found in our database for LeonaBio, Inc..

LeonaBio, Inc. Debt Obligations

InstrumentDescriptionConfidenceEvidence
LONA-DEBT-10762 Warrants outstanding: 4579000 90% xbrl warrant detail from xbrl 2025-12-31.
LONA-DEBT-10763 Xbrl Convertible 90% xbrl convertible detail from xbrl 2020-12-31.
LONA-DEBT Debt stack $691,000 90% Market cache reports total debt of $691,000.

LeonaBio, Inc. Acquisitions

No acquisitions on recordNo completed or pending acquisitions found in our database for LeonaBio, Inc..

LeonaBio, Inc. Ownership

HolderNameConfidenceEvidence
LONA-OWNER-PERCEPTIVE-ADVISORS-LLC PERCEPTIVE ADVISORS LLC 90% 13F overlay lists PERCEPTIVE ADVISORS LLC as top holder; 40 tracked holders.

LeonaBio, Inc. Extended Supply Chain Network

TickerNameChain IndexHopsRelationship Types
OVID Ovid Therapeutics Inc. 100.00 2
VKTX Viking Therapeutics, Inc. 100.00 2
ELUT Elutia Inc. 100.00 2
SGMO Sangamo Therapeutics, Inc. 100.00 2
PLX Protalix BioTherapeutics, Inc. 100.00 2
OBIO Orchestra BioMed Holdings, Inc. 100.00 2
CRMD CorMedix Inc. 100.00 2
AGEN Agenus Inc. 100.00 2
OABIW OmniAb, Inc. 50.00 2
XOMA XOMA Royalty Corporation 50.00 2
DNTH Dianthus Therapeutics, Inc. 50.00 2
XOMAP XOMA Royalty Corporation 50.00 2
LGND Ligand Pharmaceuticals Incorporated 38.88 1 ['receiving']
RYLAZE RYLAZE 23.09 2
LLY Eli Lilly and Company 14.78 2
PVLA Palvella Therapeutics, Inc. 14.78 2
SNYNF Sanofi 14.78 2